Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NTGN - Neon Therapeutics Inc

Previous close
3.07
0   0%

Share volume: 0
Last Updated: Tue 05 May 2020 06:00:00 AM CEST
Biotechnology: -0.86%

PREVIOUS CLOSE
CHG
CHG%
$3.07
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
20%
Profitability 25%
Dept financing 7%
Liquidity 34%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$3.07
P/E Ratio 
N/A
DAY RANGE
$3.07 - $3.07
EPS 
-$2.68
52 WEEK RANGE
$0.88 - $6.15
52 WEEK CHANGE
-$47.61
MARKET CAP 
88.919 M
YIELD 
N/A
SHARES OUTSTANDING 
28.964 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$665,158
AVERAGE 30 VOLUME 
$514,779
Company detail
CEO:
Region: US
Website: https://neontherapeutics.com/
Employees: 71
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA.

Recent news